✦ LIBER ✦

407 Phase 2 study of XL184 in a cohort of ovarian cancer patients (pts) with measurable soft tissue disease

✍ Scribed by I. Vergote; A. Sella; C. Bedell; L. Ramondetta; G.I. Shapiro; K. Balic; E. Prokopczuk; L. Sauer; L. Tseng; R. Berger

Book ID: 119603090
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)72114-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

406 Phase 2 study of XL184 in a cohort o

406 Phase 2 study of XL184 in a cohort of patients (pts) with castration resistant prostate cancer (CRPC) and measurable soft tissue disease

✍ D.C. Smith; A. Spira; J. De Grève; L. Hart; S. Holbrechts; C.C. Lin; M. Hussain; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

398 Phase 2 results of XL184 in a cohort

398 Phase 2 results of XL184 in a cohort of patients (pts) with advanced melanoma

✍ H. Nechushtan; G. Edelman; G. Jerusalem; M. Gordon; H.M. Kluger; A. Moussa; I. R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

408 Phase 2 study of XL184 (BMS-907351)

408 Phase 2 study of XL184 (BMS-907351) in a cohort of patients (pts) with hepatocellular carcinoma (HCC)

✍ E. Van Cutsem; W.C. Su; J. Davis; N. Haas; T.A. Samuel; C.J. Tsao; T.S. Yang; H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

397 Phase 2 results of XL184 in a cohort

397 Phase 2 results of XL184 in a cohort of patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ C. Yasenchak; K. Nackaerts; A. Awada; S.M. Gadgeel; B. Hellerstedt; M.C. Perry; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

379 POSTER A phase I study of XL184, a M

379 POSTER A phase I study of XL184, a MET, VEGFR2, and RET kinase inhibitor, administered orally to patients (pts) with advanced malignancies, including a subgroup of pts with medullary thyroid cancer (MTC)

✍ R. Kurzrock; S. Sherman; D. Hong; C. Ng; J. Frye; L. Janisch; M.J. Ratain; R. Sa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB

A phase 2 study of temsirolimus (CCI-779

A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas : A study of the Mayo phase 2 consortium (P2C)

✍ Scott Okuno; Howard Bailey; Michelle R. Mahoney; Douglas Adkins; William Maples; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views